You are here

Triplix

Abbott Drug Faces U.S. Scrutiny Over Lack of Heart Benefits

Bloomberg

Tue, 05/17/11 - 09:53 am

Abbott Laboratories

Impax challenges patent on Abbott's Trilipix

Yahoo/AP

Mon, 03/15/10 - 04:17 pm

Abbott Laboratories

AstraZeneca to co-promote Abbott's Trilipix

Marketwatch

Thu, 06/4/09 - 08:59 am

Abbott Laboratories